Developing computational model-based diagnostics to analyse clinical chemistry data

Briefings in Bioinformatics

Volumn 11, Issue 4, 2010, Pages 403-416

  van Schalkwijk, Daniël B ^a,b   van Bochove, Kees ^a,c   van Ommen, Ben ^a   Freidig, Andreas P ^d   van Someren, Eugene P ^a   van der Greef, Jan ^a,b   de Graaf, Albert A ^a  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c TUFTS UNIVERSITY   (United States)

^d Amsterdam Molecular Therapeutics   (Netherlands)

Author keywords

Clinical chemistry; Clinical diagnostics; Computational modelling; Lipoprotein metabolism; Particle profiler; Probabilistic and deterministic modelling

Indexed keywords

ARTICLE; COMPUTER SIMULATION; DIAGNOSIS; HUMAN;

COMPUTER SIMULATION; DIAGNOSIS; HUMANS;

EID: 77955044095     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbp071     Document Type: Article

References (45)

1. Ben-Zvi A, Vernon SD, Broderick G. Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction. PLoS Comput Biol 2009;5(1): e1000273. doi:10.1371/journal.pcbi.1000273.
2. Clark TJ, Barton PM, Coomarasamy A, et al. Investigating postmenopausal bleeding for endometrial cancer: costeffectiveness of initial diagnostic strategies. BJOG 2006; 113:502-10.
3. Danhof M, de Lange ECM, la Pasqua OE, et al. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research. Trends Pharmacol Sci 2008;29:186-91.
4. Rajman I. PK/PD modelling and simulations: utility in drug development. Drug Discov Today 2008;13:341-6.
5. Steinman DA. Image-based computational fluid dynamics: a new paradigm for monitoring hemodynamics and atherosclerosis. Curr DrugTargets Cardiovasc Haematol Disord 2004;4: 183-97.
6. Oresic M, Vidal-Puig A, Hännninen V. Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Rev Mol Diagn 2006;6:575-85.
7. Scalbert A, Brennan L, Fiehn O, et al. Mass-spectrometrybased metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 2009;5:435-458.
8. Picardi A, Pozzilli P. Dynamic tests in the clinical management of diabetes. J Endocrinol Invest 2003;26:99-106.
9. Lutz AM, Willmann JK, Cochran FV, et al. Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes. PLoS Med 2008;5:e170.
10. Mari A, Pacini G, Murphy E, et al. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24:539-48.
11. Iakovidis I, Wilson P, Healy JC. E-health: Current Situation and Examples of Implemented and Beneficial e-health Applications. Fairfax, V.A., U.S.A.: IOS Press, 2004.
12. Martin-Martin LS, Latini A, Pagano A, et al. A new mathematical model based on clinical and laboratory variables for the diagnosis of Sjögren's syndrome. Clin Rheumatol 2003; 22:123-6.
13. Wei JT, Zhang Z, Barnhill SD, et al. Understanding artificial neural networks and exploring their potential applications for the practicing urologist. Urology 1998;52: 161-72.
14. Schneider J, Peltri G, Bitterlich N, et al. Fuzzy logic-based tumor marker profiles including a new marker tumor M2PK improved sensitivity to the detection of progression in lung cancer patients. Anticancer Res 2003;23:899-906.
15. Kiran M, Coakley S, Walkinshaw N, et al. Validation and discovery from computational biology models. Biosystems 2007;93:141-50.
16. Sun T, McMinn P, Coakley S, et al. An integrated systems biology approach to understanding the rules of keratinocyte colony formation. J R Soc Interface 2007;4: 1077-92.
17. Hoops S, Sahle S, Gauges R, et al. COPASI-a COmplex PAthway SImulator. Bioinformatics 2006;22:3067-74.
18. Needham CJ, Bradford JR, Bulpitt AJ, et al. A primer on learning in Bayesian networks for computational biology. PLoS Comput Biol 2007;3:e129 doi:10.1371/journal.pcbi.0030129.
19. Friedman N, Linial M, Nachman I, et al. Using Bayesian networks to analyze expression data. J Comput Biol 2004;7: 601-20.
20. Hecker M, Lambeck S, Toepfer S, et al. Gene regulatory network inference: data integration in dynamic models-a review. Biosystems 2009;96:86-103.
21. Doucet P, Sloep PB. Mathematical Modeling in the Life Sciences. Chichester, Great Britain: Ellis Horwood, 1992.
22. Panteleev A, Ananyeva NM, Ataullakhanov FI, et al. Mathematical models of blood coagulation and platelet adhesion: clinical applications. Curr Pharm Des 2007;13: 1457-67.
23. van Schalkwijk DB, de Graaf AA, van Ommen B, et al. Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size. J Lipid Res 2009;50:2398-411.
24. Akobeng AK. Understanding diagnostic tests 1: sensitivity, specificity and predictive values. Acta Paediatr 2007;96: 338-41.
25. Obuchowski NA. ROC analysis. AJR Am J Roentgenol 2005; 184:364-72.
26. Nissen SE, Tardif JC, Nicholls SJ, et al. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J. Med 2007;356:1304-16.
27. Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N. Engl J Med 2007;357:2109-22.
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
29. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39.
30. Forster LF, Stewart G, Bedford D, et al. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates. Atherosclerosis 2002;164:129-45.
31. Staels B, Dallongeville J, Auwerx J, et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998;98:2088-93.
32. Otvos JD, Jeyarajah EJ, Bennett DW. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 1991;37:377-86.
33. Usui S, Hara Y, Hosaki S, et al. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res. 2002; 43:805-14.
34. Park I, Paeng KJ, Yoon Y, et al. Separation and selective detection of lipoprotein particles of patients with coronary artery disease by frit-inlet asymmetrical flow field-flow fractionation. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 780:415-22.
35. Chung BH, Segrest JP, Cone JT, et al. High resolution plasma lipoprotein cholesterol profiles by a rapid, high volume semi-automated method. J Lipid Res. 1981;22: 1003-14.
36. Mora S, Otvos JD, Rifai N, et al. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009;119:931-9.
37. Austin MA, King MC, Vranizan KM, et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
38. Packard CJ, Demant T, Stewart JP, et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid. Res 2000;41:305-18.
39. Ashyraliyev M, Fomekong-Nanfack Y, Kaandorp JA, et al. Systems biology: parameter estimation for biochemical models. FEBS J 2009;276:886-902.
40. Press WH, Teukolsky SA, Vetterling WT, et al. Numerical Recipies:TheArt of Scientific Computing. 3rd edn. Cambridge, Great Britain: Cambridge University Press, 2007.
41. Nocedal J, Wright SJ. Numerical Optimization. New York, N.Y., U.S.A.: Springer, 2000.
42. Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. SIAM J Appl. Math 1963;11:431-41.
43. Beck K. Test Driven Development: By Example. AddisonWesley Professional, 2002.
44. Lanzén A, Oinn T. The Taverna Interaction Service: enabling manual interaction in workflows. Bioinformatics 2008;24:1118-20.
45. Freedman DS, Otvos JD, Jeyarajah EJ, et al. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham study. Clin Chem 2004;50:1189-200.